253 related articles for article (PubMed ID: 20510389)
61. Multiplex target protein imaging in tissue sections by mass spectrometry--TAMSIM.
Thiery G; Shchepinov MS; Southern EM; Audebourg A; Audard V; Terris B; Gut IG
Rapid Commun Mass Spectrom; 2007; 21(6):823-9. PubMed ID: 17294518
[TBL] [Abstract][Full Text] [Related]
62. New developments in MALDI imaging for pathology proteomic studies.
Wisztorski M; Lemaire R; Stauber J; Menguelet SA; Croix D; Mathé OJ; Day R; Salzet M; Fournier I
Curr Pharm Des; 2007; 13(32):3317-24. PubMed ID: 18045185
[TBL] [Abstract][Full Text] [Related]
63. Proteomic analysis of the tetraspanin web using LC-ESI-MS/MS and MALDI-FTICR-MS.
André M; Le Caer JP; Greco C; Planchon S; El Nemer W; Boucheix C; Rubinstein E; Chamot-Rooke J; Le Naour F
Proteomics; 2006 Mar; 6(5):1437-49. PubMed ID: 16404722
[TBL] [Abstract][Full Text] [Related]
64. Identification of early intestinal neoplasia protein biomarkers using laser capture microdissection and MALDI MS.
Xu BJ; Li J; Beauchamp RD; Shyr Y; Li M; Washington MK; Yeatman TJ; Whitehead RH; Coffey RJ; Caprioli RM
Mol Cell Proteomics; 2009 May; 8(5):936-45. PubMed ID: 19164278
[TBL] [Abstract][Full Text] [Related]
65. The synergy of elemental and biomolecular mass spectrometry: new analytical strategies in life sciences.
Becker JS; Jakubowski N
Chem Soc Rev; 2009 Jul; 38(7):1969-83. PubMed ID: 19551177
[TBL] [Abstract][Full Text] [Related]
66. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
[TBL] [Abstract][Full Text] [Related]
67. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
[TBL] [Abstract][Full Text] [Related]
68. New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry.
Chaurand P; Norris JL; Cornett DS; Mobley JA; Caprioli RM
J Proteome Res; 2006 Nov; 5(11):2889-900. PubMed ID: 17081040
[TBL] [Abstract][Full Text] [Related]
69. Proteomic strategies for the characterization and the early detection of lung cancer.
Massion PP; Caprioli RM
J Thorac Oncol; 2006 Nov; 1(9):1027-39. PubMed ID: 17409991
[TBL] [Abstract][Full Text] [Related]
70. Biomarker Signature Discovery from Mass Spectrometry Data.
Kong A; Gupta C; Ferrari M; Agostini M; Bedin C; Bouamrani A; Tasciotti E; Azencott R
IEEE/ACM Trans Comput Biol Bioinform; 2014; 11(4):766-72. PubMed ID: 26356346
[TBL] [Abstract][Full Text] [Related]
71. Comparative proteomic analysis of normal and tumor stromal cells by tissue on chip based mass spectrometry (toc-MS).
Escher N; Ernst G; Melle C; Berndt A; Clement JH; Junker K; Friedrich K; Guntinas-Lichius O; von Eggeling F
Diagn Pathol; 2010 Jan; 5():10. PubMed ID: 20205871
[TBL] [Abstract][Full Text] [Related]
72. Prostate cancer diagnosis and characterization with mass spectrometry imaging.
Kurreck A; Vandergrift LA; Fuss TL; Habbel P; Agar NYR; Cheng LL
Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):297-305. PubMed ID: 29209003
[TBL] [Abstract][Full Text] [Related]
73. The cancer cell secretome: a good source for discovering biomarkers?
Pavlou MP; Diamandis EP
J Proteomics; 2010 Sep; 73(10):1896-906. PubMed ID: 20394844
[TBL] [Abstract][Full Text] [Related]
74. The use of laser capture microscopy in proteomics research--a review.
Kunz GM; Chan DW
Dis Markers; 2004; 20(3):155-60. PubMed ID: 15502248
[No Abstract] [Full Text] [Related]
75. [Proteomics and biomarkers for detection of endometrial carcinoma].
Kacerovský M; Tosner J
Ceska Gynekol; 2009 Aug; 74(4):274-8. PubMed ID: 20564981
[TBL] [Abstract][Full Text] [Related]
76. Proteomic analysis of gliomas.
Whittle IR; Short DM; Deighton RF; Kerr LE; Smith C; McCulloch J
Br J Neurosurg; 2007 Dec; 21(6):576-82. PubMed ID: 18071984
[TBL] [Abstract][Full Text] [Related]
77. Highly Multiplexed Immunohistochemical MALDI-MS Imaging of Biomarkers in Tissues.
Yagnik G; Liu Z; Rothschild KJ; Lim MJ
J Am Soc Mass Spectrom; 2021 Apr; 32(4):977-988. PubMed ID: 33631930
[TBL] [Abstract][Full Text] [Related]
78. Cytological Cytospin Preparation for the Spatial Proteomics Analysis of Thyroid Nodules Using MALDI-MSI.
Piga I; Pagni F; Magni F; Smith A
Methods Mol Biol; 2023; 2688():95-105. PubMed ID: 37410287
[TBL] [Abstract][Full Text] [Related]
79. Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS.
Sanders ME; Dias EC; Xu BJ; Mobley JA; Billheimer D; Roder H; Grigorieva J; Dowsett M; Arteaga CL; Caprioli RM
J Proteome Res; 2008 Apr; 7(4):1500-7. PubMed ID: 18386930
[TBL] [Abstract][Full Text] [Related]
80. Brain Region-Specific Dynamics of On-Tissue Protein Digestion Using MALDI Mass Spectrometry Imaging.
Heijs B; Tolner EA; Bovée JV; van den Maagdenberg AM; McDonnell LA
J Proteome Res; 2015 Dec; 14(12):5348-54. PubMed ID: 26544763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
